Insmed Inc. buy Wells Fargo & Company
Start price
08.12.23
/
50%
€25.80
Target price
08.12.24
€51.16
Performance (%)
-11.63%
Price
20.05.24
€22.80
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -11.63%. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.390% | -3.390% |
| iShares Core DAX® | 0.051% | 5.593% |
| iShares Nasdaq 100 | 1.808% | 7.445% |
| iShares Nikkei 225® | 2.181% | 2.815% |
| iShares S&P 500 | 1.040% | 4.975% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $55.00 price target on the stock.
Ratings data for INSM provided by MarketBeat